Mosby's 2022 Nursing Drug Reference
Mosby (Verlag)
978-0-323-82607-5 (ISBN)
Content on more than 5,000 generic and brand-name drugs covers almost every drug you will encounter in clinicals.
Safety Alert feature icon highlights the most critical interactions and side effects that you must be aware of during clinicals.
Black Box Warning feature alerts you to FDA warnings of potentially life-threatening reactions.
Bold heading and details on IV drug administration so students can easily find appropriate dosage and IV instructions to help them administer these drugs safely.
Side effects information is logically organized by body system and identified as common or life threatening, alerting students to the signs to watch for during assessments.
Nursing Process Framework organizes all nursing care steps so students learn how to easily and completely incorporate the nursing process into their clinical experiences.
Cross-reference headers in the book listings and in the appendicies make it easier to find the drug content quickly and less likely that students will think a drug is missing if it's not first found in the book.
Complete pharmacokinetic tables explain the mechanism and absorption of the drug, as well as the action, duration, and excretion of the drug.
NEW! Approximately 20 monographs on newly released, FDA-approved drugs give you the intricate details you need both in the classroom and clinicals. Each monograph includes new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information - so you'll feel confident in the accuracy of the information and in preventing medication dispensing errors.
NEW! Up-to-date content on drug therapies provides you with instant access to the latest information.
Linda Skidmore-Roth, RN, MSN, NP has been the lead author of Mosby's Nursing Drug Reference for more than 25 years and as such is synonymous with the Mosby imprint as a trusted name in nursing pharmacology information
Drug categories
Alpha-adrenergic blockers
Anesthetics--general/local
Antacids
Anti-alzheimer agents
Antianginals
Antianxiety agents
Antiasthmatics
Anticholinergics
Anticoagulants
Anticonvulsants
Antidepressants
Antidiabetics
Antidiarrheals
Antidysrhythmics
Antiemetics
Antifungals (systemic)
Antihistamines
Antihypertensives
Antiinfectives
Antilipidemics
Antineoplastics
Antiparkinson agents
Antiplatelets
Antipsychotics
Antipyretics
Antiretrovirals
Antituberculars
Antitussives/expectorants
Antivirals
Beta-adrenergic blockers
Bone resorption inhibitors
Calcium channel blockers
Cardiac glycosides
Cholinergics
Cholinergic blockers
Corticosteroids
Diuretics
Histamine H2 antagonists
Immunosuppressants
Laxatives
Neuromuscular blocking agents
Nonsteroidal antiinflammatories
Opioid analgesics
Salicylates
Sedatives/hypnotics
Skeletal muscle relaxants
Thrombolytics
Thyroid hormones
Vasodilators
Vitamins
Individual drugs in A-Z Format
Appendices
A. Selected new drugs
B. Recent FDA drug approvals
C. Ophthalmic, otic, nasal, and topical products
D. Vaccines and toxoids
E. Antitoxins and antivenins
F. Herbal products
G. Combination products
H. Medications that may be inappropriate for geriatric patients
I. Drugs metabolized by known P450's
J. Safety in handling chemotherapeutic agents
K. High-alert drugs
L. Controlled substance chart
M. Immunization schedules for children and adolescents
N. High-alert Canadian medications
O. Canadian controlled substance chart
P. Canadian recommended immunization schedules for infants and children
Q. FDA pregnancy categories
R. Weights and equivalents
S. Abbreviations
Erscheinungsdatum | 08.07.2021 |
---|---|
Reihe/Serie | Skidmore Nursing Drug Reference |
Verlagsort | St Louis |
Sprache | englisch |
Maße | 111 x 187 mm |
Gewicht | 1160 g |
Themenwelt | Schulbuch / Wörterbuch ► Lexikon / Chroniken |
Medizin / Pharmazie ► Pflege ► Ausbildung / Prüfung | |
ISBN-10 | 0-323-82607-5 / 0323826075 |
ISBN-13 | 978-0-323-82607-5 / 9780323826075 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich